Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Authors
Keywords
Glycolysis, Drug targets, Redox enzymes, Cancer therapy, Ruthenium drugs
Journal
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
Volume 19, Issue 6, Pages 853-867
Publisher
Springer Nature
Online
2014-02-22
DOI
10.1007/s00775-014-1120-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
- (2013) Gopinath Sutendra et al. Frontiers in Oncology
- Synthesis and Biological Studies of Pyrazolyl-Diamine PtIIComplexes Containing Polyaromatic DNA-Binding Groups
- (2012) Sofia Gama et al. CHEMBIOCHEM
- New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins
- (2012) Cristina P. Matos et al. INORGANICA CHIMICA ACTA
- Putting together a plasma membrane NADH oxidase: A tale of three laboratories
- (2012) Hans Löw et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
- (2012) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
- (2012) Simone Cardaci et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate: Targets and outcomes
- (2012) Maria C. Shoshan JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
- (2012) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- [RuII(η5-C5H5)(bipy)(PPh3)]+, a promising large spectrum antitumor agent: Cytotoxic activity and interaction with human serum albumin
- (2012) Ana Isabel Tomaz et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- Lactate: A Metabolic Key Player in Cancer
- (2011) F. Hirschhaeuser et al. CANCER RESEARCH
- A QM/MM study of the binding of RAPTA ligands to cathepsin B
- (2011) Antonella Ciancetta et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
- (2011) E Babu et al. ONCOGENE
- Trans-Plasma Membrane Electron Transport in Mammals: Functional Significance in Health and Disease
- (2010) Domenico Del Principe et al. ANTIOXIDANTS & REDOX SIGNALING
- A role for Na+/H+exchangers and intracellular pH in regulating vitamin C-driven electron transport across the plasma membrane
- (2010) Darius J.R. Lane et al. BIOCHEMICAL JOURNAL
- DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands
- (2010) Virtudes Moreno et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Inhibition of trans-plasma membrane electron transport: A potential anti-leukemic strategy
- (2010) Cecilia Prata et al. LEUKEMIA RESEARCH
- Metabolic Targeting of Malignant Tumors: Small-Molecule Inhibitors of Bioenergetic Flux
- (2010) Saroj P. Mathupala Recent Patents on Anti-Cancer Drug Discovery
- Transplasma membrane electron transport comes in two flavors
- (2009) Darius J. R. Lane et al. BIOFACTORS
- Platinum Drug Distribution in Cancer Cells and Tumors
- (2009) Alice V. Klein et al. CHEMICAL REVIEWS
- Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
- (2009) Jan Reedijk EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Trans–cis–cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B
- (2009) Pasquale Mura et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
- (2009) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
- Targeting of cancer energy metabolism
- (2009) Sara Rodríguez-Enríquez et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents
- (2008) Anna F. A. Peacock et al. Chemistry-An Asian Journal
- New trends for metal complexes with anticancer activity
- (2008) Pieter CA Bruijnincx et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Glycolytic enzyme inhibitors in cancer treatment
- (2008) Roberto Scatena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
- Homocysteine is a potent modulator of plasma membrane electron transport systems
- (2008) Javier Rodríguez-Alonso et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)−Arene Compounds
- (2008) Angela Casini et al. JOURNAL OF MEDICINAL CHEMISTRY
- A highly sensitive colorimetric microplate ferrocyanide assay applied to ascorbate-stimulated transplasma membrane ferricyanide reduction and mitochondrial succinate oxidation
- (2007) Darius J.R. Lane et al. ANALYTICAL BIOCHEMISTRY
- Antitumour metal compounds: more than theme and variations
- (2007) Michael A. Jakupec et al. DALTON TRANSACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now